{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T05:42:51Z","timestamp":1775713371941,"version":"3.50.1"},"reference-count":25,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1136\/bjophthalmol-2016-309749","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T21:21:49Z","timestamp":1487884909000},"page":"1334-1339","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Risk factors of recurrence of macular oedema associated with branch retinal vein occlusion after intravitreal bevacizumab injection"],"prefix":"10.1136","volume":"101","author":[{"given":"Jun Ho","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaemoon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeryung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaehyung","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-309749-1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1442-9071.1980.tb00340.x","article-title":"Macular oedema and retinal branch vein occlusion","volume":"8","author":"Greer","year":"1980","journal-title":"Aust J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-2","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"key-10.1136\/bjophthalmol-2016-309749-3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000337157","article-title":"Anti-vascular endothelial growth factor treatment for retinal vein occlusions","volume":"227","author":"Campochiaro","year":"2012","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2016-309749-4","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/IAE.0b013e3181aa8e20","article-title":"Intravitreal injection of bevacizumab for macular edema secondary to branch retinal vein occlusion: results after 12\u2005months and multiple regression analysis","volume":"29","author":"Kondo","year":"2009","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309749-5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/IAE.0b013e318195ca65","article-title":"Bevacizumab compared with macular laser grid photocoagulation for cystoid macular edema in branch retinal vein occlusion","volume":"29","author":"Russo","year":"2009","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309749-6","doi-asserted-by":"crossref","first-page":"209735","DOI":"10.1155\/2013\/209735","article-title":"Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion","volume":"2013","author":"Ahn","year":"2013","journal-title":"Biomed Res Int"},{"key":"key-10.1136\/bjophthalmol-2016-309749-7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1755-3768.2011.02298.x","article-title":"Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion","volume":"91","author":"Higashiyama","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bjophthalmol-2013-303121","article-title":"Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion","volume":"98","author":"Hikichi","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ophtha.2010.12.034","article-title":"Economic considerations of macular edema therapies","volume":"118","author":"Smiddy","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309749-10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3111\/13696998.2014.909435","article-title":"A United Kingdom-based economic evaluation of ranibizumab for patients with retinal vein occlusion (RVO)","volume":"17","author":"Taylor","year":"2014","journal-title":"J Med Econ"},{"key":"key-10.1136\/bjophthalmol-2016-309749-11","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ophtha.2011.02.022","article-title":"Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study","volume":"118","author":"Brown","year":"2011","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309749-12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ophtha.2014.08.031","article-title":"Intravitreal aflibercept for macular edema following branch retinal vein occlusion: the 24-week results of the VIBRANT study","volume":"122","author":"Campochiaro","year":"2015","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-309749-13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10384-011-0087-2","article-title":"Intravitreal injection of bevacizumab combined with macular grid laser photocoagulation for macular edema in branch retinal vein occlusion","volume":"55","author":"Hayashi","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.5301\/ejo.5000085","article-title":"Combined intravitreal bevacizumab and grid laser photocoagulation for macular edema secondary to branch retinal vein occlusion","volume":"22","author":"Donati","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.5301\/ejo.5000448","article-title":"Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion","volume":"24","author":"Farese","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-16","doi-asserted-by":"crossref","first-page":"434","DOI":"10.5301\/EJO.2010.6101","article-title":"Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion","volume":"21","author":"Salinas-Alam\u00e1n","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-17","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1167\/iovs.13-13738","article-title":"Quantification of the image obtained with a wide-field scanning ophthalmoscope","volume":"55","author":"Oishi","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309749-18","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1097\/IAE.0b013e31820c83c2","article-title":"Changes in areas of capillary nonperfusion after intravitreal injection of bevacizumab in eyes with branch retinal vein occlusion","volume":"31","author":"Terui","year":"2011","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309749-19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1167\/iovs.14-15673","article-title":"Analysis of retinal nonperfusion using depth integrated optical coherence tomography images in eyes with branch retinal vein occlusion","volume":"56","author":"Sakimoto","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-309749-20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00417-004-1087-4","article-title":"Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion","volume":"244","author":"Noma","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":"Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/112067210801800628","article-title":"Changes of vascular endothelial growth factor after vitrectomy for macular edema secondary to retinal vein occlusion","volume":"18","author":"Noma","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-23","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00417-009-1167-6","article-title":"Predictive factors for changes in macular edema in intravitreal bevacizumab therapy of retinal vein occlusion","volume":"248","author":"Ach","year":"2010","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-309749-24","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/IAE.0b013e31804a7af2","article-title":"Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease","volume":"27","author":"Matsumoto","year":"2007","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-309749-25","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00417-015-3225-6","article-title":"Recurrence of macular edema in eyes with branch retinal vein occlusion changes the diameter of unaffected retinal vessels","volume":"254","author":"Im","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-309749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T04:54:15Z","timestamp":1601096055000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-309749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,9,26]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.1136\/bjophthalmol-2016-309749"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309749","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727343852.793544725","asserted-by":"object"}]},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}